These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12151951)

  • 1. Useful information about the pharmacokinetics and pharmacodynamics of midazolam and lorazepam.
    Deem S
    Anesthesiology; 2002 Aug; 97(2):522; author reply 522-3. PubMed ID: 12151951
    [No Abstract]   [Full Text] [Related]  

  • 2. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Eur J Clin Pharmacol; 2006 Mar; 62(3):185-94. PubMed ID: 16425056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
    Barr J; Zomorodi K; Bertaccini EJ; Shafer SL; Geller E
    Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling and ICU sedation: unexplored territories.
    Bailey JM
    Anesthesiology; 2001 Aug; 95(2):281-2. PubMed ID: 11506095
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers.
    Chung JY; Cho JY; Yu KS; Kim JR; Jung HR; Lim KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2005 Jun; 77(6):486-94. PubMed ID: 15961980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing up with midazolam in the neonatal and pediatric intensive care.
    Swart EL; Slort PR; Plötz FB
    Curr Drug Metab; 2012 Jul; 13(6):760-6. PubMed ID: 22452456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged sedation of lorazepam due to absent UGT2B4/2B7 glucuronidation.
    Siller N; Egerer G; Weiss J; Mikus G
    Arch Toxicol; 2014 Jan; 88(1):179-80. PubMed ID: 24352535
    [No Abstract]   [Full Text] [Related]  

  • 9. Lorazepam concentrations, pharmacokinetics and pharmacodynamics in a cohort of mechanically ventilated ICU patients.
    de Wit M; Best AM; Epstein SK; Greenblatt DJ
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):466-73. PubMed ID: 17063976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.
    Shudofsky KN; Janssen PKC; Foudraine N; le Noble JLML
    J Clin Pharmacol; 2022 Apr; 62(4):568-570. PubMed ID: 34793610
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients.
    MacLaren R; Sullivan PW
    Pharmacotherapy; 2005 Oct; 25(10):1319-28. PubMed ID: 16185175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.
    Peeters MY; Prins SA; Knibbe CA; Dejongh J; Mathôt RA; Warris C; van Schaik RH; Tibboel D; Danhof M
    Anesthesiology; 2006 Dec; 105(6):1135-46. PubMed ID: 17122576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
    Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation.
    Fromm MF; Schwilden H; Bachmakov I; König J; Bremer F; Schüttler J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1129-33. PubMed ID: 17786417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midazolam and other benzodiazepines.
    Olkkola KT; Ahonen J
    Handb Exp Pharmacol; 2008; (182):335-60. PubMed ID: 18175099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
    Cleton A; Mazee D; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of midazolam in infants and children.
    Blumer JL
    Clin Pharmacokinet; 1998 Jul; 35(1):37-47. PubMed ID: 9673833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccadic eye movements in determination of the residual effects of the benzodiazepines.
    Salonen M; Aaltonen L; Aantaa E; Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):227-31. PubMed ID: 2942494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacodynamics of midazolam administered by target controlled infusion in SICU patients after CABG surgery.
    Somma J; Donner A; Zomorodi K; Sladen R; Ramsay J; Geller E; Shafer SL
    Anesthesiology; 1998 Dec; 89(6):1430-43. PubMed ID: 9856718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.